Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$240M |
| 2 |
eBay
EBAY
|
+$231M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$216M |
| 4 |
Ameren
AEE
|
+$196M |
| 5 |
Kohl's
KSS
|
+$182M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$552M |
| 2 |
Micron Technology
MU
|
+$425M |
| 3 |
Visa
V
|
+$225M |
| 4 |
Marathon Petroleum
MPC
|
+$225M |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
+$218M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.17% |
| 2 | Healthcare | 12.72% |
| 3 | Technology | 12.27% |
| 4 | Industrials | 11.44% |
| 5 | Consumer Discretionary | 11.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARRY
2126
PUT
DELISTED
Array Biopharma Inc
ARRY
| $2.78M | ﹤0.01% |
+170,500
| New | +$2.73M |
|
2127
TriMas Corp
TRS
$1.44B
| $2.78M | ﹤0.01% |
105,924
+88,360
| +503% | +$2.29M |
|
2128
ANI Pharmaceuticals
ANIP
$1.71B
| $2.77M | ﹤0.01% |
47,544
+44,288
| +1,360% | +$2.81M |
|
2129
Protagonist Therapeutics
PTGX
$9.8B
| $2.75M | ﹤0.01% |
320,739
+128,009
| +66% | +$2.41M |
|
|
HDNG
2130
DELISTED
Hardinge Inc
HDNG
| $2.75M | ﹤0.01% |
+150,048
| New | +$2.74M |
|
2131
Amkor Technology
AMKR
$12B
| $2.75M | ﹤0.01% |
271,266
+118,051
| +77% | +$1.23M |
|
|
MDC
2132
DELISTED
M.D.C. Holdings, Inc.
MDC
| $2.75M | ﹤0.01% |
114,794
+21,332
| +23% | +$564K |
|
2133
Quanterix
QTRX
$127M
| $2.75M | ﹤0.01% |
161,132
-351,853
| -69% | -$7.05M |
|
2134
Beazer Homes USA
BZH
$884M
| $2.72M | ﹤0.01% |
170,788
-140,450
| -45% | -$2.49M |
|
2135
Old Dominion Freight Line
ODFL
$41.4B
| $2.72M | ﹤0.01% |
55,548
-476,703
| -90% | -$22.6M |
|
2136
Barnes & Noble Education
BNED
$434M
| $2.71M | ﹤0.01% |
3,933
-8,814
| -69% | -$6.21M |
|
2137
Cytosorbents Corp
CTSO
$22.6M
| $2.71M | ﹤0.01% |
384,330
+220,353
| +134% | +$1.67M |
|
|
AIMT
2138
DELISTED
Aimmune Therapeutics
AIMT
| $2.71M | ﹤0.01% |
+85,136
| New | +$3M |
|
2139
AMC Global Media
AMCX
$524M
| $2.71M | ﹤0.01% |
52,372
+16,719
| +47% | +$868K |
|
2140
Coty
COTY
$2.41B
| $2.7M | ﹤0.01% |
147,729
+48,080
| +48% | +$944K |
|
|
COL
2141
PUT
DELISTED
Rockwell Collins
COL
| $2.7M | ﹤0.01% |
20,000
+8,600
| +75% | +$1.17M |
|
2142
EPR Properties
EPR
$4.6B
| $2.69M | ﹤0.01% |
48,508
-838,861
| -95% | -$48.6M |
|
2143
PUT
Agilent Technologies
A
$43.8B
| $2.68M | ﹤0.01% |
+40,000
| New | +$2.8M |
|
2144
Jabil
JBL
$32.6B
| $2.67M | ﹤0.01% |
93,094
-247,704
| -73% | -$6.75M |
|
2145
Ceragon Networks
CRNT
$189M
| $2.67M | ﹤0.01% |
992,076
+963,058
| +3,319% | +$2.36M |
|
2146
EXL Service
EXLS
$5.69B
| $2.67M | ﹤0.01% |
239,185
-316,420
| -57% | -$3.78M |
|
|
AMPE
2147
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
| $2.66M | ﹤0.01% |
2,608
+1,990
| +322% | +$1.67M |
|
|
FIT
2148
CALL
DELISTED
Fitbit, Inc. Class A common stock
FIT
| $2.65M | ﹤0.01% |
+520,000
| New | +$2.77M |
|
2149
RenaissanceRe
RNR
$13.8B
| $2.65M | ﹤0.01% |
+19,142
| New | +$2.49M |
|
|
NAVG
2150
DELISTED
Navigators Group Inc
NAVG
| $2.64M | ﹤0.01% |
45,831
-90,038
| -66% | -$4.73M |
|
Similar funds
Israel Englander's Q1 2018 Portfolio in Review
As of Q1 2018, Israel Englander held 4,417 positions worth $74.9B, up 3.4% from $72.5B the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.
Israel Englander deployed $3.29B of net new capital in Q1 2018, opening 664 new positions and adding to 1,466 existing holdings. Its largest new stake was Tiffany & Co.: 1,078,847 shares worth $105M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $552M trimmed.
- Israel Englander's largest Q1 2018 buy was Tiffany & Co.: 1,078,847 shares worth $105M.
- Israel Englander added most to Boston Scientific in Q1 2018, an estimated $240M increase.
- Israel Englander's biggest Q1 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $552M.
- Israel Englander fully exited Equinix in Q1 2018, selling an estimated $152M.
- Israel Englander's ten largest holdings make up 6.3% of its $74.9B portfolio in Q1 2018.
- Israel Englander opened 664 new positions and closed 833 in Q1 2018.
- Israel Englander's portfolio value rose 3.4% quarter-over-quarter to $74.9B.
Based on Millennium Management's 13F filing for Q1 2018, filed 15 May 2018.